Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 295 of 1,261
  1. US 11197923

    Methods and compositions for live attenuated viruses

    Takeda Vaccines, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  2. US 11198686

    Crystal form and salt form of pyridone compound and preparation method therefor

    Medshine Discovery Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  3. US 11197812

    Cosmetic formulations for topical applications containing erythropoietin-derived molecules

    ASC REGENITY LIMITED · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  4. US 11197907

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  5. US 11191774

    Drug formulations for cancer treatment

    The Regents of the University of California · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  6. US 11191763

    HIV post-exposure prophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  7. US 11191761

    SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion

    Shanghai Acebright Pharmaceuticals Group Co., Ltd. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  8. US 11191757

    Combination of pimavanserin and cytochrome P450 modulators

    ACADIA Pharmaceuticals Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  9. US 11191750

    Use of mTOR inhibitors for treatment of familial adenomatous polyposis

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  10. US 11191737

    Enhanced delivery epinephrine compositions

    Aquestive Therapeutics, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  11. US 11191727

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  12. US 11191747

    Pyrrole compounds

    Aligos Therapeutics, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  13. US 11192869

    CFTR regulators and methods of use thereof

    The Regents of the University of California · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  14. US 11193128

    Compositions for modulating expression of C9ORF72 antisense transcript

    Ionis Pharmaceuticals, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  15. US 11192958

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  16. US 11192978

    Reversibly crosslinked micelle systems

    The Regents of the University of California · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  17. US 11193129

    Modulatory polynucleotides

    VOYAGER THERAPEUTICS, INC. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  18. US 11192944

    Methods of inducing complement activity

    Bioverativ USA Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  19. US 11192923

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  20. US 11192903

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  21. US 11192898

    MDM2 protein degraders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  22. US 11192886

    S1P1 agonist and application thereof

    Medshine Discovery Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  23. US 11192885

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  24. US 11192861

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.